Fig. 1From: Translatability score revisited: differentiation for distinct disease areasDrug approvals in 2012–2016. a Approvals in percent of total analyzed drugs as per therapeutic area. b US Drug approvals as per year. Primary y-axis (continuous lines): approval in percent of total US approvals as per year, secondary y-axis (broken line): total numbers of US approvals as per yearBack to article page